Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for medicinal products (open house procedure)
Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)
Germany · Stuttgart
Contract
BuyerAOK Baden-Württemberg
TypeSupplies
Estimated valuevalue not published
Published21 April 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 17 | 2017–2025 |
| Novartis Pharma GmbH · Nürnberg | 15 | 2013–2025 |
| Bayer Vital GmbH · Leverkusen | 14 | 2013–2025 |
| Janssen-Cilag GmbH · Neuss | 13 | 2014–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 13 | 2021–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201942
202026
202139
202227
202332
202482
20252
2025112
202638
Who knows the rhythm prepares instead of reacting.
61
days until the deadline — Tuesday 20 October at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →